Share on pinterest acid reflux drugs may increase stomach cancer risk, according to a recent study on a global basis, stomach cancer is the fifth most common cancer and the third leading cause of. Acid reflux meds and cancer. A class of drugs commonly used to treat acid reflux and heartburn has been linked to a greater-than-doubled risk of developing stomach cancer, a study has found proton pump inhibitors (ppis) are used to suppress acid production in the stomach and are among the most widely sold drugs in the world, but a 2017 study revealed that long-term use of the medicine can increase stomach cancer risks.
acid reflux meds and cancer
Preliminary testing found both brand name and generic versions of the heartburn and acid reflux drug contained a nitrosamine impurity called ndma, or nitrosodimethylamine, the fda and the european. People who have frequent episodes of acid reflux are also at a slightly increased risk for developing esophageal cancer. seeking treatment for acid reflux can help decrease the likelihood of. In addition to chronic acid reflux and barrett’s esophagus, there are several other known risk factors for esophageal cancer. gender. men are three times more likely than women to be diagnosed.
